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Abstract 
 
Background: Herpes Zoster Ophthalmicus (HZO) affects the eye and adenexa and is often associated with 
severe ocular morbidity and neuralgic pain. It primarily affects the elderly and immunosuppressed 
people. Atypical clinical manifestations are more likely to occur in HIV positive patients than in 
immunocompetent individuals. Post herpetic neuralgia (PHN) forms one of the most chronic and 
distressing non-ocular complication of HZO. Objectives: To determine the spectrum of ocular 
complications, factors influencing visual prognosis, the effect of HIV-AIDS on the spectrum of ocular 
complications and the spectrum of post herpetic neuralgia in patients with Herpes Zoster OphthaImicus.  
Materials and Methods: In this prospective interventional study, all patients who presented to the Department 
of Ophthalmology within 3 weeks of the onset of active zoster-vesicle formation affecting the ophthalmic 
branch of the trigeminal nerve were included. Patients with post herpetic neuralgia were referred to the 
Department of Neuropsychiatry. Patients with pre-existing ocular disorders  were excluded from the 
study. Results: The most common predisposing condition seen in this study was HIV infection, w h i c h  w a s  
s e e n  i n  4 4 . 2 %  ( 1 9 / 43) of the patients. A peak incidence was seen in the age group, between 21-60 
years. A positive Hutchinson's sign correlated significantly with the ocular manifestations of decreased 
corneal sensation, acute corneal lesions and uveitis. Corneal involvement was seen in 95.3% (41/ 43). 
Uveitis was seen in 44.2% (19/43) of the patients. The visual outcome in most of the patients was good 
with maximum patients having no visual loss. Acute herpetic pain was seen in 97.7% (42/43) patients. Post-
herpetic neuralgia was seen in 41.9% (18/43) patients. About 53% of the patients had no visual loss at 6 
months follow-up, while 27.9% had mild-moderate visual loss and only 13.9% had severe visual loss. 
There were only 6 patients who had severe visual loss. Conclusion: HZO is more frequently presenting at a 
younger age, due to an increasing incidence of HIV AIDS. Patients w i t h  n a s o c i l i a r y  a n d  l a c r i ma l  
n e r v e  involvement and the presence of Hutchison's sign are more likely to have serious ocular 
complications. Visual loss is more likely in this group, warranting close follow-up and prompt 
treatment. The spectrum of ocular complications in immunosuppressed did not significantly differ from 
the immunocompetent patients. The overall good outcome in this study is due to the u se of early 
intensive antiviral therapy.  
Keywords: Acyclovir, Herpes Zoster Ophthalmicus, HIV-AIDS, Hutchinson's sign, Post-herpetic 
neuralgia
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Herpes Zoster Ophthalmicus is the term used for 
shingles involving the dermatome supplied by 
the ophthalmic division of trigeminal nerve. It is 
caused by the reactivation of varicella zoster 
virus. Involvement of the ophthalmic nerve by 
herpes zoster ranges in frequency from 8% to 
56% in various series [1]. In HZO, ocular 
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involvement is seen in more than 50% of the 
patients[1]. Classically, HZO begins with flu-like 
symptoms including fever, myalgia, and malaise 
for approximately one week. Typically, patients 
then develop a painful unilateral dermatomal 
rash in the distribution of one or more branches 
of V1: supraorbital, lacrimal, and nasocilliary. 
The skin manifestations usually begin as an 
erythematous macular rash, progressing over 
several days into papules, vesicles, and then 
pustules[1,2]. In this study, the spectrum of 
ocular complications in patients with HZO was 
studied. Factors influencing ocular complications 
and visual outcome were evaluated. The effect of 
HIV-AIDS on the spectrum of ocular 
complications in HZO was also evaluated. 
Patients of post herpetic neuralgia were referred 
to Neuropsychiatry for appropriate management.  
Aims and objectives 
1. To determine the spectrum of ocular 
complications in patients with Herpes zoster 
ophthalmicus 
2. To determine the factors influencing visual 
prognosis in patients with herpes zoster 
ophthalmicus. 
3. To evaluate the effect of HIV-AIDS on the 
spectrum of ocular complications in patients 
with herpes zoster ophthalmicus 
4. To evaluate the spectrum of post-herpetic 
neuralgia 
Materials and methods 
T his  s tud y was  co nd uc ted  in  t he  
Depar tment  o f  Ophtha lmology,  M.G.M 
Medical College & LS.K Hospital, Kishanganj, 
Bihar during the period August 2014 to July 2015 
on patients who presented to the Department of 
Ophthalmology or were referred from the 
departments of Dermatology, General Medicine 
and  Neuropsychia t ry.  Al l  pa tie nts  who  
presented to the Department of Ophthalmology within 
3 weeks of the onset of active zoster vesicle formation 
affecting the ophthalmic branch of the trigeminal 
nerve were included. Patients with pre-existing 
corneal diseases, glaucoma. uveitis and severe 
retinal diseases were excluded. Forty three 
patients were included in the study. 
A detailed history including information 
regarding past medical disorders, ocular 
diseases and drug history was obtained. History of 
blood transfusions and sexual history were 
specially asked for.  All the details were 
collected on a proforma specially designed for 
this study. They underwent a complete physical, 
dermatological, neuropsychiatric and ophtha- 
lmologic examination. Laboratory investigations 
like hemoglobin, total and differential count, blood 
sugar, renal function tests and ELISA for HIV (with 
informed consent) was done. Tzanck smear on the 
vesicular fluid was done for all the patients and the 
diagnosis confirmed. The ophthalmological 
examination included assessment of visual acuity, 
anterior segment using slit lamp bio-microscopy 
and fundus examination with the indirect 
ophthalmoscope. 
Herpetic pain was recorded at each visit based on 
ratings on a 4-point verbal scale as described by Zaal 
et.al [3]. These were then classified as acute, to include 
pain at the initial visit and then at 1, 2 and 4 week 
visits. Post-herpetic neuralgia was the chronic pain that 
persisted one month after the rash onset. There is 
controversy regarding the definition of post-herpetic 
neuralgia. The definition of post-herpetic neuralgia 
differs in literature. Some studies consider neuralgic 
pain persisting 3 months after rash onset as post-
herpetic neuralgia, while in ophthalmic literature it is 
considered as pain persisting one month after rash 
onset. In our study, the definition most commonly used 
in ophthalmic literature was used. 
Follow-up visits: Patients were recalled for a complete 
ophthalmic, neuropsychiatric and general physical 
examination at 1, 2 and 4-week intervals, then at 3 
months and finally at 6 months. At each visit the 
ophthalmological examination included best-corrected 
visual acuity (BCVA), corneal sensitivity, slit lamp 
examination, ocular motility testing and fundus 
examination. 
Treatment: All patients received oral acyclovir (800 
mg, five times daily) for 7-10 days. Antibiotic drops, 
cycloplegics and lubricating eye drops for ocular 
surface protection were also prescribed. Patients, who 
developed stromal keratitis or iridocyclitis, were started 
on topical steroids. If the skin involvement was severe, 
oral steroids were administered in the dose of 1 mg/kg 
body weight.  
Most of the patients were seen as outpatients 
although few were admitted for severe edema, 
intractable acute herpetic pain and treatment of other 
systemic conditions-like uncontrolled sugars etc. Post 
herpetic neuralgia was managed with tricyclic 
antidepressants and analgesics by neuropsychiatrists. 
All data were analyzed by standard statistical 
procedures. 
 
Results  
 
Age Distribution: The study showed that the range of 
age group was between 6-75 years, the median of 
 
Asian Pac. J. Health Sci., 2019; 6(2):135-141                                            e-ISSN: 2349-0659, p-ISSN: 2350-0964 
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Choudhary et al                         ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2019;6(2):135-141                                    137 
www.apjhs.com       
 
which is 44 years. A peak incidence was seen in the age group, between 21-60 years. 
Table 1: Demographic and Clinical Characteristics of Study Participants 
Range of age group 6-75 years 
Median age 44 years 
Male 23% 
Female 20% 
Predisposing factors 
HIV infection 
Age 
hypertension 
diabetes mellitus 
tuberculosis 
 
44.2% 
20.9% 
13.9% 
11.6% 
9.3%) 
 
Sex Distribution: Almost equal sex distribution (male-23% and female 20%) was found. 
Predisposing Factors: HIV infection was the most common (44.2%) predisposing factor seen among the patients, 
followed by age (20.9%), hypertension (13.9%), diabetes mellitus (11.6%) and tuberculosis (9.3%) [Table 1]. 
Visual Outcome: The visual outcome in most of the patients was good with 56.09% of the patients having no visual 
loss. About 56% of the patients had no visual loss at 6 months follow-up, 28% had mild-moderate visual loss and 
only 13.9% had severe visual loss. There were only 6 patients who had severe visual loss. 
Table 2: Visual Outcome among Study Participants 
Visual Outcome Percentage 
No visual loss at 6 months follow-up 56.09% 
Mild-moderate visual loss 28% 
Severe visual loss 13.9% 
 
Ocular Complications: In the acute phase of ophthalmic zoster, conjunctival hyperaemia was seen in 41 (95.3%), 
which subsided within 2 weeks. Punctate keratitis was seen in 41 (95.3%) patients at the initial visit, it subsided by 4 
weeks in most of the patients except in 3 patients in whom it was present even at 6 months. One of these patients 
had showed severe upper lid scarification, which led to constant inferior keratitis. The other two patients had 
associated keratoconjunctivitis sicca. Acute dendritic keratitis was seen in most patients in the first 2 weeks, which 
gradually subsided. None of the patients had persistent dendritic keratitis. None of these patients demonstrated late 
corneal epithelial keratitis suggestive of prolonged viral activity. At 2 weeks follow-up, corneal stromal infiltration 
was seen in four patients and increased to six patients at 4 weeks. Among the six patients who developed stromal 
keratitis, four had nummular and two had disciform keratitis. This however subsided in all patients by 6 months. 
None of these patients developed persistent corneal edema or neurotrophic ulceration [Table 3]. 
Acute iridocyclitis was seen at mostly the first and second follow-ups at 1 and 2 weeks respectively. At the 
end of 6 months, none of these patients had persistent uveitis and none of the patients were found to be steroid-
dependent. Secondary glaucoma was seen only in two patients. 
Table 3: Complications among Study Participants 
Visual Outcome Percentage 
Conjunctival hyperaemia 41 (95.3%) 
Punctate keratitis 41 (95.3%) 
Uveitis  44.2% (19/43) 
Constant inferior keratitis 2.33% (01/43)  
Acute herpetic pain   97.7% (42/43) 
Post-herpetic neuralgia  41.9% (18/43) 
 
Herpetic pain and post herpetic neuralgia: About 25 
patients had severe acute herpetic pain at the onset, and 
this persisted in the first week. However, at 6 months 
follow-up, only 5 patients had severe post-herpetic 
neuralgia. Post herpetic neuralgia was also found to be 
higher in the older patients with a mean of 53.1 years. 
Age did not correlate significantly with the other ocular 
manifestations like conjunctival signs, corneal 
sensation, acute or chronic corneal signs, uveitis and 
acute herpetic pain. 
Correlation of diabetes mellitus with ocular 
manifestations and post herpetic neuralgia:Diabetes 
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Mellitus did not correlate significantly with the ocular 
manifestations like conjunctival signs, corneal 
sensation, acute or chronic comeal signs, uveitis and 
acute or post herpetic pain. 
Correlation of HIV-AIDS with ocular 
manifestations and post herpetic neuralgia: HIV-
AIDS did not correlate significantly with the ocular 
manifestations like conjunctival signs, corneal 
sensation, acute or chronic corneal signs, uveitis and 
acute or post herpetic pain. 
Correlation of HIV-AIDS with age: It was found that 
HIV-AIDS was seen more often in the younger age 
group with a mean of about 36.8 years. 
Correlations of involvement of various branches of 
ophthalmic nerve with severity of ocular 
complications and post herpetic neuralgia: The 
involvement of the frontal nerve, a branch of the 
ophthalmic nerve did not correlate significantly with 
the ocular manifestations of conjunctival signs, corneal 
sensation, acute or chronic corneal signs, uveitis and 
acute or post herpetic pain. The involvement of the 
nasociliary nerve, a branch of the ophthalmic nerve 
correlated significantly with the ocular manifestations 
of corneal sensation, acute corneal signs like punctate 
and dendriform keratitis, uveitis and post herpetic pain. 
The involvement of the lacrimal nerve, a branch of the 
ophthalmic nerve correlated significantly with the 
ocular manifestations of decreased corneal sensation 
and uveitis. It did not correlate with conjunctival 
lesions, acute or chronic corneal lesions, and acute or 
post herpetic pain. The Hutchinson’s sign being 
positive correlated significantly with the ocular 
manifestations of decreased corneal sensation, acute 
corneal lesions like punctate and dendriform keratitis 
and uveitis. It did not correlate with conjunctival 
lesions, chronic corneal Igsions, and acute or post 
herpetic pain. 
Correlation of visual acuity with various ocular 
complications: Visual acuity was lower in patients 
who had decreased comeal sensation. Visual acuity 
was also found to be decreased in patients with acute 
corneal lesions like punctate and dendriform keratitis, 
uveitis and in severe post herpetic neuralgia. 
Discussion 
The commonest predisposing condition seen 
in this study was HIV infection, which was seen in 
44.2% of the patients. Age is the commonest 
predisposing factor in most studies[4,5]. A peak 
incidence was seen in the younger age group (21-60 
years) in our study, unlike the previous studies where 
the older people (>60 years) were predominantly 
affected. This was because we had included both 
immunocompromised and immunocompetent patients. 
HIV-AIDS was seen more often in the younger age 
group with a mean of about 36.8 years.In this series, 
the frontal nerve, branch of the ophthalmic nerve, was 
most commonly involved (86%). This concurs with 
various other studies including Karbassi et.al[6]. The 
nasociliary and lacrimal branches were almost equally 
involved, in 55.8% and 53.5% of the patients 
respectively. Isolated frontal nerve involvement was 
more common than the classic distribution along the 
ophthalmic branch of the trigeminal nerve. As expected 
only frontal nerve involvement did not correlate 
significantly with any ocular complications. However, 
the presence of nasociliary nerve involvement 
correlated significantly with the ocular manifestations 
of corneal sensation, acute corneal signs like punctate 
and dendriform keratitis, uveitis and post herpetic pain. 
The involvement of the lacrimal nerve, a branch of the 
ophthalmic nerve also correlated significantly with the 
ocular manifestations of decreased corneal sensation 
and uveitis[7]. This finding has not been reported in the 
other studies. 
In our study, a positive Hutchinson's sign 
correlated significantly with the ocular manifestations 
of decreased corneal sensation, acute corneal lesions 
like punctate and dendriform keratitis and uveitis. Zaal 
et al have found Hutchinson's sign to be a powerful 
predictor of ocular inflammation in HZO, with a 
relative risk of 3.35[3]. Corneal involvement was seen 
in 95.3% (41/43), which is much higher than most 
other studies. However most of these corneal lesions 
were resolved completely without any sequelae. 
Leisegang found 65% (61/94) of the patients to have 
corneal involvement[4].Zaal et al, reported 63% 
corneal involvement, which included mainly acute 
epithelial keratitis and stromal keratitis.5 Kestelyn et 
al[8] and Sandor et.al[9] found a very high incidence of 
corneal complications in HIV positive patients at 
89.4% (17/19) and at 43% (23/54) respectively. 
The acute corneal lesions were seen in 70.7% 
(29/43) of the patients in our study and dendriform 
keratitis. They responded well to oral acyclovir, topical 
antibiotics and lubricants. Comeal lesions of a chronic 
nature were observed in only 14% (6/43) of the 
patients. These chronic corneal lesions are mainly 
stromal keratitis, which included nummular keratitis (in 
4 patients) and disciform keratitis (in 2 patients). At 2 
months follow-up, these stromal lesions, possibly 
attributed to a delayed immune response to persisting 
virus antigen, were still observed in the eyes of two 
patients. They were treated with topical steroids for 
several weeks and subsided within the six months 
follow-up period. Visual acuity was also significantly 
lowered in these patients. McGill reported a 40% 
incidence for nummular keratitis in HZO[10]. More 
recently Zaal et al reported an incidence of 50%[3]. 
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Cobo et al found that those treated with antiviral agents 
were less likely to get stromal keratitis at 25% as 
compared to the non-treated group at 56%[10]. The 
lower incidence of stromal keratitis and their resolution 
in most of our patients without complications is due to 
the intensive antiviral therapy and the prompt 
instillation of topical steroids at an early stage. 
In this study, none of patients developed long 
term corneal complications like bullous keratopathy, 
mucous plaques or neurotrophic keratitis. However, 
corneal sensitivity was reduced in 30.2% (13/43) of the 
patients. This decreased sensation was significantly 
associated with the involvement of the nasociliary and 
lacrimal branches of the trigeminal nerve and a positive 
Hutchinson’s sign[11]. Visual acuity was also 
significantly lowered in patients who had decreased 
corneal sensation. But this did not lead to treatment-
refractory corneal ulceration or perforation in herpes 
zoster-affected eyes, suggesting permanent nerve 
damage. Leisegang and Womack found 17.44% 
(15/86) of the patients to have neurotrophic keratitis, 
and these patients did not receive antiviral therapy[12]. 
Uveitis was seen in 44.2% (19/43) of the 
patients. Among these patients, 47.39% (9/19) of the 
HIV patients had uveal involvement as compared to 
41.6% (10/24) of the non-HIV patients. Anterior 
uveitis is fairly common in HZO and has been reported 
in nearly 30% of the patients by Zaal et al[3], however, 
Womack et al. encountered a slightly larger number at 
43%, which was similar to our study[12]. Use of 
antiviral agents did not decrease the incidence of 
uveitis, however it reduced the severity of 
inflammation thereby improving visual outcome in the 
series reported by Severson EA et.al[13]. Acute non-
granulomatous iridocyclitis was seen at mostly the first 
and second follow-ups at 1 and 2 weeks respectively. 
Uveitis is never seen at the initial presentation as seen 
in our study. Hence it is important to inform the patient 
regarding the possibility of developing uveitis during 
the course of the disease and the need for regular 
follow-up. These patients were started on topical 
corticosteroids and cycloplegics to which they 
responded well. At the end of 6 months, none of these 
patients had persistent uveitis. Secondary glaucoma 
was seen only in two patients. This does not concur 
with the trial by Cobo et al who reported elevated IOP 
in 43% of patients early in the course of the 
disease[10,14].Acute herpetic pain was seen in 97.7% 
(42/43) patients. Post-herpetic neuralgia was seen in 
51.2% (21/41) patients. This value was found higher 
than that seen in the other series. Post herpetic pain was 
seen more often in the older age group with a mean of 
about 53.1 years. The more severe cases were elderly 
patients and in those with involvement of the 
nasociliary nerve. Harding et al[15]. found an increased 
incidence of PHN in their study with increasing age, 
male sex and severe acute pain as the risk factors. 
Involvement of nasociliary nerve and ocular 
involvement did not increase the risk in their study. 
The pain resolved with medical management only. 
They were treated with tricyclic antidepressants and 
analgesics. The patients who had post-herpetic 
neuralgia had a significantly lower visual acuity, an 
observation not reported in other studies. However, this 
finding is not unexpected as PHN is more likely to 
occur in severe disease, which is also associated with 
more visual loss. Various studies report incidence rates 
ranging from 15-20% for post herpetic neuralgia. 
Harding et al[15] found 21% incidence of PHN in their 
study, which was less than that seen in our study. 
Severity and the incidence of PHN were also found to 
be higher in HIV positive patients by Kestelyn et 
al[8]However Margolis et al do not concur with this 
with only 2.4% (2/74) of patients developing PHN in 
their study, which included only patients with HIV[16]. 
Patients with prolonged PHN often suffer 
ongoing disturbances in physical and psychosocial 
functioning. In severe cases, PHN can lead to drug 
dependency, depression and even suicide. Effective 
pain management programs for these patients need to 
be developed. Combinations of all these medications 
and not a ‘single drug was in help managing the PHN. 
Older patients and patients with visual loss, who are 
more likely to develop PHN according to our findings, 
require careful follow-up and early treatment for PHN. 
In this series, we did not encounter any posterior 
segment complications.The visual outcome seen in our 
series concurs with the various other studies, where 
HZO has a good visual outcome unless serious retinal 
lesions occur[12]. About 53% of the patients had no 
visual loss at 6 months follow-up, while27.9% had 
mild-moderate visual loss and only 13.9% had severe 
visual loss. There were only 6 patients who had severe 
visual loss. One was due to phthisis bulbi in a HIV 
patient due to severe inflammation resulting from non-
compliance of medication. The other 5 patients had 
complications like posterior subcapsular cataract in 4 
and secondary glaucoma in 1 patient. Visual acuity was 
lower in patients who had decreased corneal sensation. 
Visual acuity was also found to be decreased in 
patients with acute comeal lesions like punctate and 
dendriform keratitis, uveitis and in severe post herpetic 
pain. Patients with HZO should be monitored 
frequently to detect these ocular complications 
associated visual loss to prevent permanent visual loss. 
HIV-AIDS was the most common 
predisposing factor seen among the patients in this 
series. The spectrum of ocular complications in HIV 
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patients, seen in our series was similar to that seen and 
reported by Kestelyn where 89.4% patients had corneal 
involvement and 52.6% had uveitis[8]. Sandor et al 
reported keratitis and uveitis in 57% of their patients, 
which was less than that seen in our series[9]. Margolis 
et al reported stromal keratitis in 35% of the patients, 
which was more than that seen in our series[16]. They 
reported iritis in 50% of their patients, which concurs 
with our study. But they had a low incidence of PHN at 
4% compared to our series. They also reported that 4 % 
of the patients had developed necrotizing retinitis, 
which was not seen in our series. 
Presence of HIV infection did not increase the 
incidence of ocular complications like acute or chronic 
keratitis, uveitis, acute herpetic pain or PHN. There 
was no significant difference in the occurrence of 
ocular complications in the immunocompromised and 
immunocompetent patients, except in the severity of 
rash[17]. The HIV patients in our series had 
involvement of the adjacent maxillary and mandibular 
dermatome along with the ophthalmic dermatome more 
often than the immunocompetent patients. This was not 
reported in the other studies. None of our patients had 
posterior segment complications of HZO like ARN and 
PORN. These conditions were important causes of 
visual loss in HIV patients in the series reported by 
Margolis et al[16]. We have no explanation for this 
difference. The anterior segment complications seen in 
the HIV positive patients in our series concurs with the 
findings of Margolis et al[16]. This is because the 
patients in both the studies received early intensive 
antiviral therapy. In contrast patients reported by 
Kestelyn et al[8] and Sandor et al[9]had more severe 
ocular complications resulting in poor visual outcome 
as their patients did not receive antiviral therapy. 
Although the incidence of anterior segment 
complications was comparable or more than these two 
series, the final visual outcome was better in our study. 
This could be attributed to the early intensive antiviral 
therapy. In this series, none of the HIV positive 
patients developed chronic infective dendriform 
comeal lesions as reported by Margolis et al[16]. These 
lesions occur only in HIV positive patients with HZO 
and are cause for severe distressing intractable pain in 
these patients. 
Conclusion 
The involvement of the nasociliary nerve, 
lacrimal nerve and the Hutchinson's sign being positive 
were associated with an increased incidence of ocular 
complications, including stromal keratitis and uveitis. 
With the increasing incidence of HIV infection, HZO is 
increasingly presenting at a younger age, as seen in our 
series. Thus, all young patients with HZO need 
serological testing for HIV. Visual loss was associated 
with the presence of decreased corneal sensation. 
Visual acuity was also found to be decreased in 
patients with acute corneal lesions like punctate and 
dendriform keratitis, uveitis and in severe post herpetic 
pain. PHN was more likely to occur in the older age 
group. The presence of nasociliary nerve involvement 
and visual loss were more likely to be associated with 
PHN, an observation not reported earlier. Early 
treatment with tricyclic antidepressants will help in 
early resolution of this distressing complication of 
HZO. Serious visual loss could be prevented in most 
patients suffering from acute ophthalmic herpes zoster 
disease if vigorous acyclovir treatment is instituted 
early. The inflammatory and immune-mediated lesions 
of HZO respond well to topical steroids. The drug has a 
definite role in the treatment of corneal, scleral or uveal 
inflammation. The non-administration or inadequate 
use of steroids in the presence of inflammatory 
complications may lead to permanent visual loss in 
these patients. 
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